Kala Pharmaceuticals, Inc. (KALA)

USD 3.75

(-11.56%)

Long Term Debt Summary of Kala Pharmaceuticals, Inc.

  • Kala Pharmaceuticals, Inc.'s latest annual long term debt in 2023 was 34.19 Million USD , down -9.88% from previous year.
  • Kala Pharmaceuticals, Inc.'s latest quarterly long term debt in 2024 Q2 was 22.83 Million USD , down -19.92% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported annual long term debt of 37.93 Million USD in 2022, down -52.27% from previous year.
  • Kala Pharmaceuticals, Inc. reported annual long term debt of 79.47 Million USD in 2021, down -20.03% from previous year.
  • Kala Pharmaceuticals, Inc. reported quarterly long term debt of 28.51 Million USD for 2024 Q1, down -16.61% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported quarterly long term debt of 33.56 Million USD for 2023 Q2, up 0.91% from previous quarter.

Annual Long Term Debt Chart of Kala Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Long Term Debt of Kala Pharmaceuticals, Inc. (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 34.19 Million USD -9.88%
2022 37.93 Million USD -52.27%
2021 79.47 Million USD -20.03%
2020 99.38 Million USD -0.47%
2019 99.85 Million USD 0.89%
2018 98.97 Million USD 725.71%
2017 11.98 Million USD 31.75%
2016 9.09 Million USD 16.72%
2015 7.79 Million USD 0.0%

Peer Long Term Debt Comparison of Kala Pharmaceuticals, Inc.

Name Long Term Debt Long Term Debt Difference
Cosmos Health Inc. 3.03 Million USD -1026.397%
Safety Shot Inc 304.9 Thousand USD -11113.255%
Bright Green Corporation 201.78 Thousand USD -16843.945%
Embecta Corp. 1.62 Billion USD 97.897%
ANI Pharmaceuticals, Inc. 309.66 Million USD 88.959%
Aquestive Therapeutics, Inc. 91.07 Million USD 62.46%
Collegium Pharmaceutical, Inc. 489.96 Million USD 93.022%
Dynavax Technologies Corporation 252.41 Million USD 86.455%
Esperion Therapeutics, Inc. 501.54 Million USD 93.183%
Intra-Cellular Therapies, Inc. 13.32 Million USD -156.566%
Pacira BioSciences, Inc. 513.79 Million USD 93.346%
PainReform Ltd. 30 Thousand USD -113866.667%
Sunshine Biopharma, Inc. 539.03 Thousand USD -6242.816%
Sunshine Biopharma, Inc. 539.03 Thousand USD -6242.816%
SCYNEXIS, Inc. 12.15 Million USD -181.191%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -29090.038%
Journey Medical Corporation 14.62 Million USD -133.826%
Alpha Teknova, Inc. 13.25 Million USD -158.018%
Procaps Group, S.A. 28.41 Million USD -20.345%
Theratechnologies Inc. 51.26 Million USD 33.302%
Harrow Health, Inc. 183.17 Million USD 81.334%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -39198.851%
Biofrontera Inc. 804 Thousand USD -4152.488%
DURECT Corporation 2.7 Million USD -1165.359%
Supernus Pharmaceuticals, Inc. 33.19 Million USD -2.994%
Cronos Group Inc. 1.55 Million USD -2093.072%
OptiNose, Inc. 611 Thousand USD -5495.745%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 93.139%
RedHill Biopharma Ltd. 455 Thousand USD -7414.286%
Organogenesis Holdings Inc. 60.74 Million USD 43.716%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 12.78 Million USD -167.441%
Radius Health, Inc. 339.66 Million USD 89.934%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD -233.301%
Phibro Animal Health Corporation 458.28 Million USD 92.54%
Procaps Group S.A. 28.41 Million USD -20.345%
Alvotech 1.02 Billion USD 96.673%
TherapeuticsMD, Inc. 6.53 Million USD -423.423%
Viatris Inc. 16.18 Billion USD 99.789%
Rockwell Medical, Inc. 8.29 Million USD -312.275%
Aytu BioPharma, Inc. 10.87 Million USD -214.333%
SIGA Technologies, Inc. 335.99 Thousand USD -10075.868%
Tilray Brands, Inc. 287.93 Million USD 88.126%
Lifecore Biomedical, Inc. 120.51 Million USD 71.629%
Shineco, Inc. 10.01 Million USD -241.308%
PetIQ, Inc. 437.82 Million USD 92.191%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 210 Thousand USD -16180.952%
Neurocrine Biosciences, Inc. 258.3 Million USD 86.763%
Alimera Sciences, Inc. 64.48 Million USD 46.983%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 38.51 Million USD 11.227%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -25209.241%
Petros Pharmaceuticals, Inc. 6.85 Million USD -398.588%
Clever Leaves Holdings Inc. 720 Thousand USD -4648.611%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -151963.69%
Avadel Pharmaceuticals plc 32.75 Million USD -4.365%
Hempacco Co., Inc. 5.93 Million USD -476.463%
Talphera, Inc. - USD -Infinity%
Alvotech 1.02 Billion USD 96.673%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 39.181%
Lantheus Holdings, Inc. 616.12 Million USD 94.451%
Currenc Group, Inc. 2.5 Million USD -1263.796%
Kamada Ltd. 7.43 Million USD -359.667%
Indivior PLC 235.66 Million USD 85.492%
Evoke Pharma, Inc. 5 Million USD -583.8%
Flora Growth Corp. 942 Thousand USD -3529.512%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -151963.69%
Evolus, Inc. 120.35 Million USD 71.593%
HUTCHMED (China) Limited 48.18 Million USD 29.05%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 94.197%
Akanda Corp. 2.49 Million USD -1269.158%